1. Introduction {#sec1}
===============

Alzheimer\'s disease (AD) exists on a continuum comprising a lengthy preclinical stage, a middle stage of mild cognitive impairment (MCI), and a final stage of dementia [@bib1]. Symptoms usually start around the age of 65 years, except in rare patients with early onset (33--60 years) autosomal dominant AD (ADAD) [@bib2], [@bib3]. Drugs currently available for AD provide limited short-term treatment of AD symptoms [@bib4]. Trials of disease-modifying therapies for AD dementia patients have been unsuccessful, likely because intervention at this stage is too late to affect the neurodegenerative process. The focus now is on therapeutic intervention at the MCI and/or preclinical disease stages, with delay of dementia onset constituting a major clinical end point for clinical trials [@bib1]. This approach depends on the identification of biomarkers that can aid early AD diagnosis [@bib1], [@bib5]. Currently, validated AD biomarkers are (1) low cerebrospinal fluid (CSF) amyloid-β 42 levels and/or high amyloid tracer retention on positron emission tomography (PET), indicating brain amyloidosis; (2) high CSF tau levels, indicating neuronal injury; (3) temporoparietal pattern of reduced 18F-fluorodeoxyglucose uptake on PET, indicating brain hypometabolism, and (4) patterns of brain atrophy on structural magnetic resonance imaging (MRI), indicating neurodegeneration [@bib1], [@bib6].

Connectivity in resting-state functional magnetic resonance imaging (rsfMRI) is an emerging AD biomarker that holds promise for early diagnosis [@bib1], [@bib5], [@bib7]. RsfMRI indirectly measures neural processing in the brain using blood oxygenation and can be used to identify spatially distributed networks [@bib8]. The National Institute on Aging--Alzheimer\'s Association lists rsfMRI functional connectivity as a potential biomarker of neuronal injury, at an early stage of validation [@bib6]. The existing literature is indeed mostly composed of proof-of-concept cross-sectional comparisons of cognitively healthy elderly individuals with patients suffering from mild (MCI) or severe (dementia) AD symptoms.

To date, multiple studies have reported intrinsic connectivity network (ICN) disturbances in patients with AD dementia and MCI, presymptomatic ADAD mutation carriers, and cognitively normal individuals carrying the at-risk APOEε4 allele and/or showing evidence of amyloidosis [@bib9], [@bib10], [@bib11], [@bib12]. Despite such promising findings, the overall effect of AD on ICNs remains poorly characterized because of several inconsistencies in the literature, such as different acquisition protocols, processing methods, and/or exclusion/inclusion criteria [@bib13]. Our aim was to perform a systematic review and meta-analysis to examine the consistency of intrinsic connectivity alterations in MCI and late-onset AD (LOAD) dementia across the literature. We also reviewed the burgeoning literature on connectivity abnormalities in ADAD and the at-risk APOEε4 genotype.

2. Methods {#sec2}
==========

2.1. Literature search {#sec2.1}
----------------------

We conducted a systematic review of PubMed articles up to December 3, 2015 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines [@bib14]. Search terms and combinations used are provided in [Supplementary Table 1](#appsec1){ref-type="sec"}. Results were filtered for duplicates within each of the two main search categories, that is, AD dementia or MCI patients ([Fig. 1](#fig1){ref-type="fig"}). Unique search results underwent further screening as described subsequently.Fig. 1Flowchart of the study selection process. Selection process for AD and MCI studies included in the meta-analyses. Studies using rsfMRI methods dissimilar to seed-based and ICA methods, such as degree centrality or graph theory, amplitude of low-frequency fluctuations, and regional homogeneity were not included. Abbreviations: AD, Alzheimer\'s disease; EEG, electroencephalogram; ICA, independent component analysis; MCI, mild cognitive impairment; MEG, magnetoencephalography; rsfMRI, resting-state functional magnetic resonance imaging.

2.2. Study selection {#sec2.2}
--------------------

Search results were subjected to two successive screenings with increasingly stringent criteria. The initial screen was performed on article abstracts. An article was included if the abstract indicated that it was a peer-reviewed original research article written in English and used rsfMRI to study LOAD and/or MCI in humans. Reviews, letters, case reports, and studies with subjects in whom MCI was associated with other diseases were omitted. Following the initial screening, we applied the following inclusion criteria: (1) used seed-based or independent component analysis rsfMRI methods; (2) investigated functional connectivity between patients (AD dementia or MCI) and age-matched healthy controls (HC); and (3) reported peak coordinates of significant statistical differences in average connectivity between groups and the direction of difference.

2.3. Data extraction {#sec2.3}
--------------------

One reviewer (A.B.) conducted the searches and screened for duplicates. Two reviewers (A.B. and A.T.) independently screened all unique search results for potential inclusion in the meta-analysis. Only articles passing both reviewers\' approval were considered for final inclusion. For each "included" article, coordinate data of significant between-group comparisons, such as AD versus HC, were transcribed by one reviewer and checked by two others (second reviewer \[A.T.\] and F.H.).

2.4. Meta-analysis {#sec2.4}
------------------

We performed complementary network- and voxel-based quantitative meta-analyses on six main group comparisons: pooled group with AD dementia and MCI patients termed ADMCI \< HC, ADMCI \> HC, MCI \< HC, MCI \> HC, AD \< HC, and AD \> HC. Although the voxel-based meta-analysis has finer spatial resolution for findings with high anatomic consistency, we assumed the network-based approach would have better sensitivity for detecting consistent involvement of anatomically distributed networks. Coordinates from articles using the same cohort were pooled under the PubMed unique identifier or PMID of the earliest publication and treated as results from a single study to avoid counting the cohort multiple times. Henceforth, an individual article will be referred to as a "study" and a group comparison yielding network and/or localization information (e.g., ADMCI \< HC) as a "contrast."

### 2.4.1. Network-based statistics {#sec2.4.1}

We performed network-based statistics on seed coordinates (seed statistics) to assess whether seed regions were preferentially selected from within certain networks in the literature. We also performed network-based statistics on coordinate data of significant contrasts (contrast statistics) to assess the consistency of network-level findings in the AD literature. In particular, we performed three types of contrast statistics: (1) all coordinates irrespective of seed network; and given the focus on the default mode network (DMN) in the literature, (2) coordinates associated with seeds inside the DMN only; and (3) coordinates associated with seeds outside the DMN, that is, non-DMN seeds. All analyses were conducted using a multiresolution atlas of group-level functional brain parcellations derived from an independent rsfMRI data set, the Bootstrap Analysis of Stable Clusters--Cambridge atlas (<https://dx.doi.org/10.6084/m9.figshare.1285615.v1>) [@bib15]. This atlas consists of nine functional parcellations capturing successively finer levels of spatial detail, of which we used parcellations at two resolutions: the first comprised seven commonly used large-scale networks (R7 atlas) and the second containing 36 networks (R36 atlas). We used R7 and R36 atlases for contrast statistics and only the R7 atlas for seed statistics. Because seeds were assigned indirectly for studies where coordinates were not provided, indirect assignment could not be performed with sufficient precision to use the R36 atlas. Assignment of seeds to one of the R7 networks was based on published coordinates, when available. When only anatomic labels were provided for seed regions, network assignment was based on (1) the center of gravity in MNI space or (2) visual approximation if no further information was available. For independent component analysis-based studies, network assignment was based on (1) network coordinates when provided or (2) visual assignment to one or more of the seven networks based on the degree of spatial overlap.

We tested the spatial consistency of both seed and peak locations using the following approach. For each study, we computed the number of coordinates falling within each network, after conversion of Talairach space coordinates into MNI space using the Lancaster transform [@bib16], when necessary. Coordinates falling outside of the gray matter mask (ICBM152) were assigned to the closest network. To remain unbiased to the number of coordinates reported per study, we computed the ratio of coordinates falling within each network to the total number of coordinates reported per study. This ratio was then averaged across studies. The significance of findings was assessed using Monte Carlo permutation tests. Using the total number of coordinates per study, we generated a random assignment of coordinates to networks, taking into consideration the volume of each network. Coordinate counts per network were normalized as described previously, followed by an averaging across studies. This Monte Carlo sampling process was repeated 10,000 times. Thereafter, we compared the distribution of the average frequency obtained from the random sampling with the frequency obtained from the meta-analysis, resulting in *P* value estimates [@bib17]. Multiple comparisons across networks were accounted for using a false discovery rate (FDR) procedure (qFDR \< 0.05) [@bib18]. The *P* values less than .05 that did not survive multiple comparisons were deemed as "trends."

### 2.4.2. Voxel-based statistics {#sec2.4.2}

Voxel-level statistical analysis was performed using activation likelihood estimation (ALE), a widely used algorithm for coordinate-based meta-analysis of neuroimaging studies. ALE aims at delineating brain regions with above-chance convergence of reported coordinates across experiments [@bib19]. Coordinates falling outside the gray matter mask were removed from the analysis. We used the in-house ALE algorithm implementation in MATLAB version 8.3.0.532, which treats each of the coordinates in a given experiment as a three-dimensional gaussian probability distribution centered at the given coordinate. The probability distributions acknowledge the spatial uncertainty associated with each experiment. For any given study, the width of the spatial uncertainty of its coordinates is determined based on empirical data on the between-subject and between-template variances representing the main components of this uncertainty [@bib19]. Then, the probability distributions of all coordinates per included study are combined for each voxel, generating a modeled activation (MA) map. To limit the effect of multiple coordinates very close to one another within a given study, we used the "nonadditive" approach, which calculates MA maps by taking the maximum probability across overlapping gaussians [@bib19]. ALE scores were computed on a voxel-by-voxel basis by taking the union across these MA maps. To distinguish between "true" and random convergence between studies (i.e., noise), ALE scores were compared with a null distribution reflecting a random spatial association between experiments (10,000 permutations). Nonparametric *P* values were assessed at a familywise error-corrected threshold of *P* \< .05 on a cluster level (cluster-forming threshold: *P* \< .001 at voxel level) and transformed into *t* scores for display purposes. Only contrasts including more than 18 experiments were considered, as recommended in a recent large-scale simulation study [@bib20].

3. Results {#sec3}
==========

3.1. Search results {#sec3.1}
-------------------

The results of the initial search, along with studies systematically excluded from inclusion in our rsfMRI meta-analyses are presented in [Fig. 1](#fig1){ref-type="fig"}. Thirty-four studies totaling 1363 subjects (post pooling of identical cohorts) met our inclusion criteria and were included in the meta-analysis. The total included 352 MCI, 378 AD dementia (specifically LOAD), and 633 HC. Diagnostic criteria used per study for MCI and AD dementia are provided in the [Supplementary Material](#appsec1){ref-type="sec"} ([Supplementary Table 2](#appsec1){ref-type="sec"} and Section [2](#sec3){ref-type="sec"}). The bulk (54%) of the studies had 20 or less subjects per group. Twenty studies (66.7%) investigated rsfMRI connectivity measures with other domains, cognition being most frequent (*n* = 11/22 AD studies, *n* = 9/15 MCI studies), and few with levels of amyloid burden using Pittsburgh compound B (*n* = 3), brain atrophy (*n* = 3), and structural connectivity (*n* = 1). Alterations in functional connectivity were often (*n* = 5/9 studies) reported to be significantly correlated with episodic verbal learning and memory in MCI cohorts. [Table 1](#tbl1){ref-type="table"} provides additional characteristics of the included rsfMRI studies, including scanner make, model, and strength, and seed region and/or ICN investigated. A summary of commonly used preprocessing steps utilized by the studies present in our meta-analysis are provided in [Supplementary Table 3](#appsec1){ref-type="sec"}.Table 1Characteristics of rsfMRI studies included in the meta-analysisStudy*N*ADHCADScannerMethodSeed region/ICN investigated*n*MFAgeSD*n*MFAgeSD\<HC\>HCWang et al. [@bib63]28147770.26.3147769.65.5x1.5 T SSBPCC**Zhang et al.**[@bib64]^a^321661071.65.1167971.34.9xx1.5 T PSBPCC**Zhang et al.**[@bib65]^a^5539182173.4167971.34.9xx1.5 T PSBPCCSheline et al. [@bib66]833548xx3.0 T SSBPrecuneusZhou et al. [@bib52]24125763.37.7125762.0xx1.5/3.0/4.0 T S/GE/B*SB* and ICAAG (l), pregenual ACC (r)Gili et al. [@bib67][∗](#tbl1fnlowast){ref-type="table-fn"}21117471.97.9107364.110.5x3.0 T S*SB* and ICAPCC, mPFC**Wu et al.**[@bib68]^b^31156964.08.3167965.09.2x3.0 T SICADMN**Li et al.**[@bib69]^b^31156964.08.3167965.09.2x3.0 T SICAATN (d, v)Damoiseaux et al. [@bib70]392191264.28.71812662.710.3xx3.0 T GEICADMN (a, p, v), SMNBinnewijzend et al. [@bib71][†](#tbl1fndagger){ref-type="table-fn"}8239231667.08.043232069.07.0x1.5 T SICADMN, working memory (l, r), visuospatial attention (d), spatial attention (v), SMN, auditory language, prVIS, sVIS, basal ganglia cerebellumKenny et al. [@bib72]321677.38.91676.38.3x3.0 T PSBHippocampus (l, r), PCC, precuneus, prVISZhu et al. [@bib73][†](#tbl1fndagger){ref-type="table-fn"}22107372.97.9125773.86.5x3.0 T GESBICC (l, r)Balthazar et al. [@bib74]372073.98.21772.36.4xx3.0 T PICADMN (d, v), SN (a, p)**Yao et al.**[@bib75]^c,^[†](#tbl1fndagger){ref-type="table-fn"}6235122372.48.527161169.26.5x3.0 T GESBAmygdala (l, r)**Zhou et al.**[@bib76]^c,^[†](#tbl1fndagger){ref-type="table-fn"}6235122372.48.527161169.26.5xx3.0 T GESBT**Zhang et al.**[@bib77]^c,^[†](#tbl1fndagger){ref-type="table-fn"}6235122372.48.527161169.26.5x3.0 T GESBMrD (l, r)Gour et al. [@bib29]28146875.12.91441072.83.0xx3.0 T SSBPCC, perirhinal cortex (l, r), dlPFC (l, r)Weiler et al. [@bib78]482261673.45.72662070.06.6xx3.0 T PSBPCC, Wernicke\'s (l); Broca\'s (l), dlPFC (l, r), saVCBalachandar et al. [@bib79]30159667.36.6159664.48.9xx3.0 T SICADMN, thalamic, ECNPasquini et al. [@bib80][∗](#tbl1fnlowast){ref-type="table-fn"}432181372.38.62261666.39.0xx3.0 T PICADMN (a, p)Adriaanse et al. [@bib28]5928171172.04.931171472.04.3x1.5 T SICADMN, VIS (med, lat), AN, SMN, ECN, dorsovisual (l, r)Yi et al. [@bib81][∗](#tbl1fnlowast){ref-type="table-fn"}231111064.22.4123971.81.2x3.0 T GEICADMN, SNStudy*N*MCIHCMCIScannerMethodSeed region/ICN investigated*n*MFAgeSD*n*MFAgeSD\<HC\>HCSorg et al. [@bib82]4024131169.38.11610668.13.8x1.5 T SICAVIS, AN, ATN (v), spatial attention, DMNBai et al. [@bib83]5630151572.54.426121471.65.3xx1.5 T GESBPCCGili et al. [@bib67][∗](#tbl1fnlowast){ref-type="table-fn"}20106471.24.1107364.110.5x3.0 T S*SB* and ICAPCC, mPFCBai et al. [@bib84]442619771.44.31810870.34.7x1.5 T GEICADMNXie et al. [@bib85]5630191172.64.826141270.34.8x1.5 T GESBPostcentral gyrus (l), hippocampus (l), medialFC (l), middleFC (l), precuneus (l, r), insula (l, r)Jin et al. [@bib86]1685360.63.284460.98.3xx3.0 T GEICADMNHan et al. [@bib87]804073386.34.540152586.34.5xx1.5 T GESBPCCLiang et al. [@bib88]321661068.57.81661067.28.4xx3.0 T SSBAG (l, r), supramarginal gyrus (l, r), intraparietal sulcus (r)Hahn et al. [@bib89][†](#tbl1fndagger){ref-type="table-fn"}5428141469.57.126101665.57.8x3.0 T PICADMN (a, p), ATN (d, v), ECN (l, r), SMN, VISMyers et al. [@bib90]352314969.37.4125963.85.2x3.0 T PICADMN (a, p), ATN (l, r, d), SN, prANKoch et al. [@bib91]4024141068.28.4167964.85.4x3.0 T PICADMN (a, p), ATN (l, r, d), SN, prANPasquini et al. [@bib80][∗](#tbl1fnlowast){ref-type="table-fn"}4422111165.38.72261666.39.0x3.0 T PICADMN (a, p)Das et al. [@bib92]6930141671.66.839182170.69.0x3.0 T SSBHippocampal subregionsGardini et al. [@bib93]422113870.64.72171469.86.5x3.0 T GESBPCC, mPFCYi et al. [@bib81][∗](#tbl1fnlowast){ref-type="table-fn"}322041671.0123971.81.2xx3.0 T GEICADMN, SN[^1][^2][^3][^4]

3.2. Network-based meta-analysis {#sec3.2}
--------------------------------

### 3.2.1. Seed statistics {#sec3.2.1}

Using network-level statistics, we demonstrated that a disproportionately large number of studies specifically targeted the DMN ([Fig. 2](#fig2){ref-type="fig"}) irrespective of the population (ADMCI, MCI, or AD dementia) being studied.Fig. 2Seed region network-level findings. (A) R7 atlas; (B) histograms showing the ratio of counts (or hits) across the seven networks for all seeds in ADMCI, MCI, and AD. Significant (^∗^ denoting qFDR \< 0.05) prevalence of seeds in the DMN was demonstrated across all three cohorts; (C) seed region hit maps (ratio of dysconnectivity coordinates in each network) at R7. Maps are superimposed onto the anatomic International Consortium for Brain Mapping (ICBM) 152 template. x, y, and z Montreal Neurological Institute (MNI) coordinates are given for sagittal, coronal, and axial slices. Abbreviations: AD, Alzheimer\'s disease; ADMCI, AD dementia and MCI; CER, cerebellar network; DMN, default mode network; FDR, false discovery rate; FPN, frontoparietal network; HC, healthy control; LIM, limbic network; MCI, mild cognitive impairment; MOT, motor network; SAL, salience network; VIS, visual network.

### 3.2.2. Contrast statistics {#sec3.2.2}

We first examined R7 network-level statistics and all seeds combined. Aberrant functional brain connectivity was observed in ADMCI, MCI, and AD, relative to HC ([Fig. 3](#fig3){ref-type="fig"}). In the ADMCI cohort, we found both significant hypoconnectivity and hyperconnectivity in the DMN. Significant hyperconnectivity in the DMN and limbic network (LIM) was observed in the MCI cohort. There was also significant hypoconnectivity in the DMN for the AD group, which appeared as a trend for the MCI group.Fig. 3Network-level findings using the R7 atlas. (A) Histograms showing per contrast the ratio of hits across the seven networks for all seeds, DMN seeds only, and non-DMN seeds. Networks with significant count (or hit) ratios are indicated by ^∗^ denoting qFDR \< 0.05, whereas ^†^ denotes *P* \< .05 uncorrected. (B) Hit maps at R7 are shown for contrasts ADMCI \< HC, ADMCI \> HC, MCI \< HC, MCI \> HC, AD \< HC, and AD \> HC. Maps are superimposed onto the anatomic ICBM 152 template. x, y, and z MNI coordinates are given for sagittal, coronal, and axial slices. Abbreviations: AD, Alzheimer\'s disease dementia; ADMCI, AD dementia and MCI; CER, cerebellar network; DMN, default mode network; FDR, false discovery rate; FPN, frontoparietal network; HC, healthy control; LIM, limbic network; MCI, mild cognitive impairment; MOT, motor network; SAL, salience network; VIS, visual network.

We then refined the spatial localization of effects found in R7 using the R36 atlas. Significant DMN hypoconnectivity in AD and ADMCI cohorts was detected in the precuneus (PCu) and posterior cingulate cortex (PCC) ([Fig. 4](#fig4){ref-type="fig"}). A trend for DMN hyperconnectivity was observed in the PCu for ADMCI and in both the PCu and PCC in MCI ([Fig. 4](#fig4){ref-type="fig"}). The LIM hyperconnectivity was observed as a trend in the hippocampus and entorhinal cortex in MCI patients ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4Network-level findings using the R36 atlas. (A) Functional template at R36 showing the breakdown of the DMN and LIM into subnetworks. These two networks were significant (qFDR \< 0.05 for contrasts ADMCI \< HC for DMN, ADMCI \> HC for DMN, MCI \> HC for DMN and LIM, AD \< HC for DMN) or trended toward significance (*P* \< .05 uncorrected for contrasts MCI \< HC for DMN) for the "all-seeds" condition at R7. (B) Histograms showing per selected contrast (as described in A), the ratio of counts (or hits) across the subnetworks. Subnetworks with significant hit ratios are indicated by ^∗^ denoting qFDR \< 0.05, whereas ^†^ denotes a trend with *P* \< .05 uncorrected. (C) Hit maps at R36 for brain regions that overlap with significant or trending toward significance networks (as described in A). Maps are superimposed onto the anatomic ICBM 152 template. x, y, and z MNI coordinates are given for sagittal, coronal, and axial slices. Abbreviations: AD, Alzheimer\'s disease dementia; ADMCI, AD dementia and MCI; CER, cerebellar network; DMN, default mode network; FDR, false discovery rate; FPN, frontoparietal network; HC, healthy control; LIM, limbic network; MCI, mild cognitive impairment; MOT, motor network; SAL, salience network; VIS, visual network.

Finally, we investigated the robustness of findings with respect to the selection of seeds (DMN, non-DMN, or all combined), using the R7 atlas. Significant network-level findings derived from all seeds combined, as reported previously, replicated when using DMN seeds alone ([Fig. 3](#fig3){ref-type="fig"}A). In addition, a trend toward hypoconnectivity in MCI became significant using DMN seeds only. When focusing on non-DMN seed studies, no significant effects were observed in the DMN, as expected. The only significant result was hyperconnectivity of the salience network (SAL) in ADMCI, also present as a trend in AD subjects.

3.3. Voxel-based meta-analysis {#sec3.3}
------------------------------

ALE results demonstrated significant hypoconnectivity in the PCC and PCu in the ADMCI and AD studies ([Fig. 5](#fig5){ref-type="fig"}, [Supplementary Table 4](#appsec1){ref-type="sec"}), consistent with our network-level findings using R7 and R36 atlases. This observation was made both for all seeds combined and DMN-only seeds ([Fig. 5](#fig5){ref-type="fig"}, [Supplementary Table 4](#appsec1){ref-type="sec"}).Fig. 5Location of significant convergence of the voxel-level findings. Regions exhibiting significant rsfMRI abnormalities for contrasts ADMCI \< HC, AD \< HC, and AD \> HC. Activation likelihood estimation images were thresholded at *P* \< .05 (cluster-level family wise error or FWE corrected for multiple comparisons; cluster-forming threshold *P* \< .001 at the voxel level) and displayed as *t* scores, with hyperconnectivity in red-orange and hypoconnectivity in blue-green. Maps are superimposed onto the anatomic ICBM 152 template. x, y, and z MNI coordinates are given for sagittal, coronal, and axial slices. Abbreviations: AD, Alzheimer\'s disease dementia; ADMCI, AD dementia and mild cognitive impairment; HC, healthy control; rsfMRI, resting-state functional magnetic resonance imaging.

Unlike the network-level analysis, using ALE we found diminished connectivity in the primary visual cortex, both in ADMCI and AD. This was observed for all seeds combined as well as for DMN-only seeds in ADMCI and DMN-only seeds in AD. Finally, significant hyperconnectivity was observed in AD in the anterior insula ([Fig. 5](#fig5){ref-type="fig"}, [Supplementary Table 4](#appsec1){ref-type="sec"}), consistent with the trend in the LIM observed using the R36 atlas.

4. Discussion {#sec4}
=============

We report on a systematic meta-analysis of rsfMRI brain connectivity dysfunction in LOAD, using voxel-, region-, and network-level statistics. Our results demonstrated consistent connectivity alterations both within and outside of the DMN.

4.1. Connectivity changes in the DMN {#sec4.1}
------------------------------------

### 4.1.1. Late-onset AD {#sec4.1.1}

Our results revealed a consistent decrease in DMN connectivity in the ADMCI and AD cohorts, particularly in the PCu and PCC, for all resolutions of meta-analysis. This finding is in line with previous meta-analyses centered on the DMN [@bib21], [@bib22], and a recent study published after we completed our analysis [@bib23]. DMN deterioration appears robust to the choice of analytical approaches, as previous meta-analyses largely included studies measuring regional homogeneity and amplitude of low-frequency fluctuation. Moreover, our results support previous literature reporting on the vulnerability of the DMN to multiple AD pathophysiology [@bib24].

Unlike our robust findings in AD subjects, DMN hypoconnectivity in MCI could only be demonstrated using network-level statistics, suggesting a weaker, more distributed effect in MCI. However, we recently reported decreased DMN connectivity in a large multisite MCI cohort with a connectome-wide approach [@bib13]. The modest findings of our present meta-analysis may be because of a lack of statistical power from having multiple, small, single-site samples. Clinical heterogeneity might also have played a role, that is, only a subset of MCI patients develop AD dementia [@bib6], [@bib25], and there may be pathologic subtypes [@bib26]. We also demonstrated DMN hyperconnectivity in MCI and ADMCI using network-level statistics. These changes may reflect both functional disconnection and compensation in response to damage at earlier stages of neurodegeneration, as well as direct or indirect pathologic mechanisms [@bib27]. Moreover, there is some uncertainty of the specific nodes that actually show aberrant connectivity in our network-level analysis. This may give rise to apparent contradictory results.

### 4.1.2. Early onset AD {#sec4.1.2}

DMN hypoconnectivity of similar magnitude to LOAD was demonstrated in early onset non--ADAD [@bib28], [@bib29], whereas in ADAD, DMN hypoconnectivity was slightly more pronounced than that in LOAD [@bib30]. Altered DMN connectivity was observed in asymptomatic mutation carriers (*PSEN1*, *PSEN2*, or *APP*) many years before the age at which they were expected to develop symptoms [@bib31], [@bib32], [@bib33], suggesting that aberrant connectivity may be a very early biomarker for AD.

### 4.1.3. Cognitively normal individuals at genetic risk for LOAD {#sec4.1.3}

Altered DMN connectivity has been reported in cognitively normal APOEε4 carriers compared with non-APOEε4 carriers. These alterations were found across all age groups, that is, elderly [@bib12], [@bib34], [@bib35], [@bib36], middle-aged [@bib37], [@bib38], [@bib39], and young adults [@bib40], [@bib41], and were associated with worse cognition in middle-aged and elderly carriers [@bib35], [@bib37], [@bib39]. Studies have also reported connectivity changes in the DMN in the absence of Pittsburgh compound B--detectable brain amyloidosis [@bib12], [@bib40], [@bib41], further validating the potential of rsfMRI connectivity as an early marker of synaptic and neuronal dysfunction in AD.

### 4.1.4. Cognitively normal elderly at risk for LOAD {#sec4.1.4}

Aberrant DMN dysconnectivity, particularly reduced connectivity between the anterior and posterior DMN, has been associated with aging and age-related cognitive decline [@bib33], [@bib42]. DMN hypoconnectivity may arise as early as middle age [@bib43], [@bib44], with decreases occurring at differing rates between sexes [@bib45] most likely due to the differential effect of sex on AD risk [@bib46]. Reduced DMN integrity has also been reported in cognitively normal elderly with abnormal levels of CSF amyloid or tau proteins [@bib47], as well as PET-detectable cerebral amyloidosis [@bib48]. These results suggest that some of the effects related to normal aging in the literature may be driven by preclinical AD. Very few studies examined the interactions between age, sex, LOAD, and rsfMRI connectivity, which is clearly an important avenue for future work.

4.2. Connectivity changes outside the DMN {#sec4.2}
-----------------------------------------

Our meta-analysis confirmed that intrinsic connectivity disruptions in LOAD are not confined to the DMN. We found increased connectivity in the SAL in ADMCI and AD. Abnormal SAL connectivity has now been reported in another LOAD study [@bib49] published after we completed our meta-analysis and has also been demonstrated in ADAD [@bib30], APOEε4 carriers [@bib36], [@bib37], and the elderly [@bib50], with connectivity increases highlighted in APOEε4 carriers. With the anterior insula as a key hub, the SAL plays a pivotal role in network switching between the DMN and frontoparietal network (FPN), two networks exhibiting competitive interactions during cognitive information processing [@bib51]. Association of heightened SAL connectivity with reduced DMN connectivity in AD suggests that progressive DMN impairment may be deleterious to SAL function [@bib52].

We also found increased connectivity in the LIM in MCI. Heightened LIM connectivity has been reported in early onset, non-ADAD patients [@bib29], and in individuals with subjective memory impairment [@bib53]. The effect of APOEε4 carriage on LIM connectivity, however, lacks consensus [@bib54], [@bib55], [@bib56]. Since LIM hyperconnectivity in early onset AD patients was shown to correlate positively with memory performance, it is likely that increased connectivity in this network contributes to preserving function in the face of medial temporal lobe pathology [@bib29].

4.3. Selective vulnerability of multimodal networks in AD {#sec4.3}
---------------------------------------------------------

The DMN, SAL, and FPN are multimodal networks that interconnect cortical regions associated with various cognitive functions, and they have been demonstrated computationally to support integrative information processing at the cost of being vulnerable to early and fast spreading of insults [@bib57]. Supporting this theoretical finding is the recent observation that tau and amyloid-β, despite their independent patterns of spatial deposition, overlap with brain tissue loss in hub regions of multimodal networks [@bib58]. These multimodal networks are also metabolically expensive and display higher rates of cerebral blood flow, aerobic glycolysis, and oxidative glucose metabolism [@bib59]. The high-value/high-cost characteristics of the DMN, SAL, and FPN may make them vulnerable to AD-associated pathogenic processes, such as metabolic dysfunction/oxidative stress, and accumulation of toxic proteins, such as amyloid-β [@bib59]. The hypothesis that multimodal networks/regions are particularly susceptible to AD-associated pathophysiological processes may explain our finding of consistent alterations of these networks.

4.4. Limitations {#sec4.4}
----------------

Our literature search did not identify an abundance of rsfMRI literature in AD and MCI cohorts, which clearly expresses the need for additional research. The relatively low number of experiments that met our inclusion criteria might have underpowered our voxel-level findings, especially for the MCI contrasts. In addition, our search demonstrated that typical studies featured small samples, and also that analytical methods were quite variable in the field (a main reason for excluding an article was due to methodology used). This setting is particularly amenable to questionable research practices, including "p-hacking" (testing several methods, reporting only one). Given the near absence of negative results reporting in the field, on one hand, and the large size of the rsfMRI field, on the other hand, there is no question that some amount of publication bias is also present. Meta-analytical tools, such as funnel plots, are available to detect both selective reporting and p-hacking but are not feasible given current reporting practices in the rsfMRI community [@bib60].

Another limitation of our study is experimental heterogeneity, in terms of population recruitment, scan acquisition (e.g., scanner make and model, scanning parameters), and processing choices [@bib13], [@bib20], [@bib61]. The prominence of the DMN in our results partly reflects the focus on this network in the literature, which we quantified using seed statistics. Hypothesis-driven analyses on the DMN are attractive for assessing connectivity changes in small samples; as such analyses will have good statistical power if the DMN truly carries the larger effects in the brain. However, full-brain studies will be required to get a more comprehensive view on AD-related changes in rsfMRI network connectivity using meta-analyses. The current trend toward large public samples [@bib13], [@bib62] is enabling unbiased meta-analyses, pooling neuroimaging data across many studies instead of relying on published coordinates. This will hopefully resolve most of the aforementioned limitations in the future.

5. Conclusions {#sec5}
==============

Our meta-analysis demonstrated consistent connectivity alterations in the DMN, SAL, and LIM in the spectrum of LOAD, supporting the use of resting-state connectivity as a biomarker of AD.Research in Context1.Systematic review: We conducted a systematic review of PubMed-indexed resting-state functional magnetic resonance imaging (rsfMRI) studies in accordance with the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" guidelines. We included studies that investigated differences in functional connectivity, relative to controls, between patients with Alzheimer\'s disease (AD) and/or mild cognitive impairment, and reported coordinates of findings.2.Interpretation: Typical rsfMRI functional connectivity studies in AD suffer from low statistical power. Our meta-analysis quantifies if and where convergent findings have been reported in the literature and strengthens the evidence for the use of rsfMRI as an AD biomarker.3.Future directions: A disproportionately large portion of studies specifically investigated the default mode network, based on well-grounded hypotheses on AD pathophysiology. It is unclear if AD truly has larger effects on default-mode connectivity because of limited power to examine other networks. Future research should aim for full-brain investigations using larger study populations.

Supplementary data {#appsec1}
==================
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[^1]: Abbreviations: a, anterior; ACC, anterior cingulate cortex; AD, Alzheimer\'s disease; AG, angular gyrus; AN, auditory network; ATN, attentional network; B, Brucker; d, dorsal; dlPFC, dorsolateral prefrontal cortex; DMN, default mode network; ECN, executive control network; F, female; GE, General Electrics; HC, healthy control; ICA, independent component analysis; ICC, isthmus of cingulate cortex; ICN, intrinsic connectivity network; l, left; lat, lateral; M, male; MCI, mild cognitive impairment; med, medial; medialFC, medial frontal cortex; middleFC, middle frontal cortex; mPFC, medial prefrontal cortex; MrD, marginal division; n, number of subjects; p, posterior; P, Philips; PCC, posterior cingulate cortex; prAN, primary auditory network; prVIS, primary visual network; r, right; rsfMRI, resting-state functional magnetic resonance imaging; S, Siemens; saVC, secondary associative visual cortex; SB, seed based; SMN, sensorimotor network; SD, standard deviation; sVIS, secondary visual network; T, Tesla; v, ventral.

[^2]: NOTE. Data provided in "bold" indicate seven studies using shared cohorts. Coordinates from these seven studies were subsequently pooled under four studies (indicated by superscript letters a, b, and c), under the corresponding earliest publication using the cohort. In column "Method", when both seed-based and ICA rsfMRI methods were used by a study, the method given in "italics" indicates the method associated with reported coordinates. For column "Seed region/ICN investigated", all seed regions and ICNs investigated are listed, irrespective of significant findings.

[^3]: Studies reporting significant coordinates for both AD and MCI patients, relative to matched HC.

[^4]: Studies investigating both AD dementia and MCI cohorts.
